Study participants
All pediatric patients (<14 years old) with confirmed hematology/oncology diagnoses and receiving high, moderate, low, and minimum emetogenic chemotherapy regimens as inpatients or outpatients were included in the study. We excluded patients with a history of vomiting or those who had received any antiemetic medication 24 h prior to commencement of chemotherapy.